Search Results

There are 13990 results for: content related to: Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

  1. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  2. You have free access to this content
    Poster Session III (Abstracts 1195 – 1637)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 601–810,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28799

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. You have free access to this content
    Liver Cancer

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1213A–1276A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26883

  5. You have free access to this content
    Poster Session 3: Cellular Immunobiology and Clinical Hepatobiliary Neoplasia

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 828A–889A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27524

  6. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1036–1047, Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana, Luigi Bolondi, Mauro Bernardi, Franco Trevisani and on behalf ofBLOG (Bologna Liver Oncology Group)

    Version of Record online : 20 MAY 2014, DOI: 10.1111/liv.12574

  7. You have free access to this content
    Poster Liver

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue S4, December 2015, Pages: 323–407,

    Version of Record online : 24 NOV 2015, DOI: 10.1111/jgh.13189

  8. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting

    Journal of Digestive Diseases

    Volume 16, Issue 3, March 2015, Pages: 143–151, Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda and Katsuaki Tanaka

    Version of Record online : 27 MAR 2015, DOI: 10.1111/1751-2980.12221

  9. You have free access to this content
    Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E130–E140, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 3 MAR 2015, DOI: 10.1111/hepr.12480

  10. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

    Liver International

    Volume 34, Issue 5, May 2014, Pages: 795–801, Ju-Yeon Cho, Yong-Han Paik, Hee Chul Park, Jeong Il Yu, Won Sohn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik and Byung Chul Yoo

    Version of Record online : 12 JAN 2014, DOI: 10.1111/liv.12445

  11. You have free access to this content
    Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety

    Hepatology

    Volume 51, Issue 1, January 2010, Pages: 165–173, Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli and Umberto Cillo

    Version of Record online : 31 AUG 2009, DOI: 10.1002/hep.23260

  12. Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 6, June 2015, Pages: 1032–1039, Li Xu, Hengjun Gao, Junting Huang, Haoyuan Wang, Zhongguo Zhou, Yaojun Zhang, Shaohua Li and Minshan Chen

    Version of Record online : 27 APR 2015, DOI: 10.1111/jgh.12910

  13. You have free access to this content
    Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 8, October 2011, Pages: 949–959, M. Pinter, W. Sieghart, F. Hucke, I. Graziadei, W. Vogel, A. Maieron, R. Königsberg, A. Weissmann, G. Kornek, J. Matejka, R. Stauber, R. Buder, B. Grünberger, M. Schöniger-Hekele, C. Müller and M. Peck-Radosavljevic

    Version of Record online : 24 AUG 2011, DOI: 10.1111/j.1365-2036.2011.04823.x

  14. You have free access to this content
    The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1458–1467, Yee Chao, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim and Teng-Yu Lee

    Version of Record online : 16 SEP 2014, DOI: 10.1002/ijc.29126

  15. You have free access to this content
    Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

    Hepatology

    Volume 54, Issue 6, December 2011, Pages: 2055–2063, Massimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia, Claudio Zavaglia, Antonio Grieco, Erica Villa, Calogero Cammà, Massimo Colombo and on behalf of the SOFIA (SOraFenib Italian Assessment) study group

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24644

  16. The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 11 MAR 2017, Yuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, Kun-Ming Rau, I-Pei Wu, Chien-Hung Chen, Kwong-Ming Kee, Tsung-Hui Hu and Sheng-Nan Lu

    DOI: 10.1111/jgh.13783

  17. You have free access to this content
    Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 784–791, Massimo Iavarone, Giuseppe Cabibbo, Marco Biolato, Cristina Della Corte, Marcello Maida, Marco Barbara, Michele Basso, Sara Vavassori, Antonio Craxì, Antonio Grieco, Carlo Cammà and Massimo Colombo

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27729

  18. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2147–2154, Yu Yang, Feng Wen, Jianliang Li, Pengfei Zhang, Wenhui Yan, Ping Hao, Feng Xia, Feng Bi and Qiu Li

    Version of Record online : 7 MAR 2015, DOI: 10.1111/liv.12805

  19. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  20. On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 8, April 2017, Pages: 1146–1155, J. Howell, D. J. Pinato, R. Ramaswami, D. Bettinger, T. Arizumi, C. Ferrari, C. Yen, A. Gibbin, M. E. Burlone, G. Guaschino, L. Sellers, J. Black, M. Pirisi, M. Kudo, R. Thimme, J.-W. Park and R. Sharma

    Version of Record online : 2 MAR 2017, DOI: 10.1111/apt.13977